Showing results (321-330 of 546) with videos related to

Sort By:
Pageof 55
Proteomics|December 5, 2008
Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparisonDavid A Cairns, Jennifer H Barrett, Lucinda J Billingham, et al.
Thorax|November 20, 2012
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trialShawn D Aaron, Katherine L Vandemheen, François Maltais, et al.
British Journal of Cancer|February 6, 2020
Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesisAmelia Acha-Sagredo, Bubaraye Uko, Paschalia Pantazi, et al.
European Journal of Radiology|September 19, 2019
Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screeningE Soo, A J Edey, S M Mak, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replicationA K Field, M E Davies, C DeWitt, et al.
BMJ Open|July 16, 2015
Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trialNoor Ali, Kate J Lifford, Ben Carter, et al.
Internal Medicine Journal|September 30, 2015
Survival impact of the Australian National Bowel Cancer Screening ProgrammeS Ananda, H Wong, I Faragher, et al.
International Journal of Cancer|May 16, 1996
Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neckP J Snijders, A G Scholes, C A Hart, et al.
Antiviral Research|December 1, 1988
Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPGB J Terry, K E Mazina, A V Tuomari, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in miceA Braitman, M R Swerdel, S J Olsen, et al.
Pageof 55